Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-23-000093

Director acquired 4,975 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Scadden David · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-06-21 Exercise or conversion : show line 1 in the form +4,975 12,095 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-06-21 Exercise or conversion : show line 2 in the form Restricted stock unit −4,975 0 D
Loading xslF345X04/wk-form4_1687552551.xml…